Faculty

D’Amore Receives HMS William Silen Lifetime Achievement in Mentoring Award

D’Amore Receives HMS William Silen Lifetime Achievement in Mentoring Award

March 24, 2016

Patricia A. D’Amore, PhD, MBA, FARVO, the Charles L. Schepens Professor of Ophthalmology and Professor of Pathology at Harvard Medical School (HMS), was selected for the prestigious HMS William Silen Lifetime Achievement in Mentoring Award. This award is one of three Excellence in Mentoring awards established by the Office for Diversity Inclusion and Community Partnership at HMS. Each year, only 18 out of more than 18,000 HMS faculty...

Read more about D’Amore Receives HMS William Silen Lifetime Achievement in Mentoring Award
Joan W. Miller

Joan W. Miller Appointed Treasurer of the Macula Society

March 9, 2016

Joan W. Miller, MD, Henry Willard Williams Professor of Ophthalmology and Chair of the Department of Ophthalmology at Harvard Medical School (HMS), was appointed Treasurer of The Macula Society as of February 27, 2016. Dr. Miller is an internationally recognized expert on retinal disorders, including age-related macular degeneration (AMD), retinal degenerations, and diabetic retinopathy. Along with...

Read more about Joan W. Miller Appointed Treasurer of the Macula Society
New Research Links Mitochondrial Dysfunction to Development of Fuchs’ Endothelial Corneal Dystrophy (FECD), a Common Cause of Corneal Swelling and Blindness

New Research Links Mitochondrial Dysfunction to Development of Fuchs’ Endothelial Corneal Dystrophy (FECD), a Common Cause of Corneal Swelling and Blindness

March 7, 2016

Findings could eventually lead to first non-surgical therapies and treatments for FECD. 

BOSTON -- Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs’ Endothelial Corneal Dystrophy (FECD)....

Read more about New Research Links Mitochondrial Dysfunction to Development of Fuchs’ Endothelial Corneal Dystrophy (FECD), a Common Cause of Corneal Swelling and Blindness
Congratulations to Our 2016 ARVO Fellows!

Congratulations to Our 2016 ARVO Fellows!

March 4, 2016

The title of ARVO Fellow is an honor established to recognize current ARVO members for their individual accomplishments, leadership and contributions to the Association. ARVO Fellows serve as role models and mentors for individuals pursuing careers in vision and ophthalmology research and help further ARVO's vision, which includes advancing basic and clinical knowledge and serving as the leading international forum for vision research and the primary advocate for vision science worldwide. In 2016, one HMS Ophthalmology faculty member and several alumni received this honor.

... Read more about Congratulations to Our 2016 ARVO Fellows!

Honors and Awards Received January-February 2016

February 15, 2016

Dong Feng Chen, PhD,  received a National Institutes of Health/National Eye Institute R01 grant in the amount of $2,462,500 over five years for her project, "The molecular basis underlying optic nerve growth in development and regeneration."

Miguel Gonzalez, MD, PhD, a Cornea KPro Research Fellow at Mass. Eye and Ear, received membership to the Royal Academy of Medicine and...

Read more about Honors and Awards Received January-February 2016
Demetrios Vavvas

Demetrios Vavvas to Receive Carl Camras Translational Research Award at ARVO 2016

March 1, 2016

Demetrios Vavvas, MD, PhD, Associate Professor of Ophthalmology at Harvard Medical School (HMS) and the Joan W. Miller Scholar in Retinal Research at Massachusetts Eye and Ear, was selected to receive a 2016 ARVO Foundation/Pfizer Ophthalmics Carl Camras Translational Research Award. The award will be presented at the...

Read more about Demetrios Vavvas to Receive Carl Camras Translational Research Award at ARVO 2016
Patients with High-Risk Macular Degeneration Show Improvement with High-Dose Statin Treatment

Patients with High-Risk Macular Degeneration Show Improvement with High-Dose Statin Treatment

February 4, 2016

A phase I/II clinical trial at Massachusetts Eye and Ear found that some patients taking high doses of atorvastatin (cholesterol-lowering medication) had complete resolution of lipid deposits in the dry form of age-related macular degeneration (AMD). AMD is the leading cause of blindness in the developed world, and though effective treatments are available for the wet AMD, they are currently lacking for the more-prevalent dry form.

...

Read more about Patients with High-Risk Macular Degeneration Show Improvement with High-Dose Statin Treatment

Honors and Awards Received December 2015

February 1, 2016

Lisa Cowan's, MD, PhD, paper, "Introducing a new surgical technology: Controversies in femtosecond laser-assisted cataract surgery and impact on resident surgical training," published in the Fall 2015 issue of International Ophthalmology Clinics, was one of the top 10 articles read in 2015 in ophthalmology. These statistics were published by Medscape. Lisa is an HMS Ophthalmology resident.

Louis...

Read more about Honors and Awards Received December 2015
Researchers Shed Light on Anti-Adhesive Molecule in Vascular Endothelium, Suggest New Direction for Anti-Inflammatory Therapy

Researchers Shed Light on Anti-Adhesive Molecule in Vascular Endothelium, Suggest New Direction for Anti-Inflammatory Therapy

February 3, 2016

Mass. Eye and Ear researchers describe the role of endomucin, a molecule that – under healthy circumstances – resists the adhesion of white blood cells as they move through the circulatory system. These findings suggest that promoting the expression of endomucin (displayed in red in image) may prevent the collection of white blood cells that causes tissues to become inflamed. 

...

Read more about Researchers Shed Light on Anti-Adhesive Molecule in Vascular Endothelium, Suggest New Direction for Anti-Inflammatory Therapy

Grants Received November and December 2015

January 29, 2016

The NIH K12 EY016335 Grant, which funds the Harvard Vision Clinical Scientist Development Program, led by Reza Dana, MD, MSc, MPH, has been renewed for funding by the NIH for an additional four years. The program awards career development grants that provide exceptional junior clinician scientists with financial support, mentorship, and 75 percent protected research time to pursue and build independent research...

Read more about Grants Received November and December 2015
The S-Stamp Eliminates the Primary Cause of Graft Failure in DMEK

The S-Stamp Eliminates the Primary Cause of Graft Failure in DMEK

January 26, 2016

Peter Veldman, MD, of Mass. Eye and Ear was first author on two recent publications related to the S-stamp for Descemet membrane endothelial keratoplasty (DMEK), a novel orientation technique that has to date eliminated upside-down graft implantation in DMEK. Dr. Veldman helped to validate and then successfully implement this technique over the last...

Read more about The S-Stamp Eliminates the Primary Cause of Graft Failure in DMEK

Pages